Meeder Asset Management Inc. Takes Position in National Research Co. (NASDAQ:NRC)

Meeder Asset Management Inc. purchased a new position in shares of National Research Co. (NASDAQ:NRC) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 6,970 shares of the company’s stock, valued at approximately $159,000.

Other large investors have also recently added to or reduced their stakes in the company. CWM LLC boosted its position in shares of National Research by 889.7% in the second quarter. CWM LLC now owns 1,158 shares of the company’s stock worth $27,000 after buying an additional 1,041 shares during the period. Quarry LP acquired a new stake in National Research during the 2nd quarter valued at $54,000. Benjamin F. Edwards & Company Inc. increased its stake in National Research by 145.6% during the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock worth $64,000 after buying an additional 1,650 shares during the period. Gladius Capital Management LP increased its stake in National Research by 164.5% during the 3rd quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock worth $70,000 after buying an additional 1,908 shares during the period. Finally, SG Americas Securities LLC acquired a new position in National Research in the 3rd quarter worth $124,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.

National Research Stock Up 1.9 %

Shares of National Research stock opened at $18.83 on Wednesday. The company has a debt-to-equity ratio of 1.30, a current ratio of 0.47 and a quick ratio of 0.47. National Research Co. has a 1-year low of $17.62 and a 1-year high of $42.38. The business has a 50-day moving average of $20.06 and a 200-day moving average of $23.29. The company has a market capitalization of $442.13 million, a PE ratio of 16.66 and a beta of 0.51.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Friday, October 25th. The company reported $0.24 earnings per share (EPS) for the quarter. The company had revenue of $35.82 million for the quarter. National Research had a return on equity of 67.40% and a net margin of 18.78%.

National Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Friday, December 27th will be paid a dividend of $0.12 per share. The ex-dividend date is Friday, December 27th. This represents a $0.48 dividend on an annualized basis and a yield of 2.55%. National Research’s dividend payout ratio (DPR) is 42.48%.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.